Scientific truth or false hope? understanding alzheimer's disease from an aging perspective

Journal of Alzheimer's Disease

Volumn 24, Issue 1, 2011, Pages 3-10

  Chen, Ming ^a,b   Maleski, Jerome J ^a   Sawmiller, Darrell R ^a  

^a Bay Pines VA Medical Center   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

aging; Alzheimer's disease; amyloid; tau

Indexed keywords

AMYLOID BETA PROTEIN;

AGING; ALZHEIMER DISEASE; DISEASE CLASSIFICATION; HUMAN; PRESENILE DEMENTIA; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENILE DEMENTIA; SOCIAL PROBLEM;

EID: 79955648520     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-101638     Document Type: Review

References (28)

1. Selkoe DJ (2005) Defining molecular targets to prevent Alzheimer disease. Arch Neurol 62, 192-195. (Pubitemid 40204739)
2. Khachaturian ZS (2007) A chapter in the development of Alzheimer's disease research: a case study of public policies on the development and funding of research programs. Alzheimers Dement 3, 243-258. (Pubitemid 46825510)
3. Chen M, Fernandez HL (2000) Revisiting Alzheimer's disease from a new perspective: can "risk factors" play a key role? J Alzheimers Dis 2, 97-108.
4. Chen M, Fernandez HL (2001) Alzheimer's disease revisited 25 years later: Is it a "disease" or senile condition? Front Biosci 6, e30-e40.
5. Chen M (2007) Was Alois Alzheimer right or wrong? Why senile dementia has been misclassified as "Alzheimer's disease" and how it confused the field. The Scientist 281, 23.
6. Fox P (1989) From senility to Alzheimer's disease: the rise of the Alzheimer's disease movement. Milbank Quarterly 67, 58-102. (Pubitemid 20041686)
7. Gillick MR (1998) Tangled minds: understanding Alzheimer's disease and other dementia. Penquin Group, New York.
8. Home Medical Dictionary (1977) PSI Publishing, Inc., Miami, Florida.
9. Katzman R (1976) The prevalence and malignancy of Alzheimer's disease: amajorkiller. Arch Neurol 33, 217-218.
10. Khachaturian ZS (2008) Robert Katzman: the man and his legacy. Alzheimers Dement 4, 377.
11. US House of Representatives, Select committee on aging, and 98th Congress (1983) Senility: the last stereotype, Pub. No. 98-390 (US Government printing house office, Washington, DC).
12. Cassel CK, Leipzig R, Cohen HJ, Larson EB, Meier DE (eds) (2003) Geriatric Medicine. 4th edn. Springer, New York.
13. Khachaturian ZS (2000) Toward a comprehensive theory of Alzheimer's disease-challenges, caveats, and parameters. Ann NY Acad Sci 924, 184-193. (Pubitemid 32050200)
14. Schneider P, Hampel H, Buerger K (2009) Biological marker candidates of Alzheimer's disease in blood, plasma, and serum. CNS Neurosci Ther 15, 358-374.
15. Fratiglioni L, Wang HX, Ericsson K, Maytan M, Winblad B (2000) Influence of social network on occurrence of dementia: a community-based longitudinal study. Lancet 355, 1315-1319. (Pubitemid 30199003)
16. Hultsch DF, Hertzog C, Small BJ, Dixon RA (1999) Use it or lose it: engaged lifestyle as a buffer of cognitive decline in aging? Psychol Aging 14, 245-263. (Pubitemid 29291561)
17. Saczynski JS, Beiser A, Seshadri S, Auerbach, S, Wolf PA, Au R (2010) Depressive symptoms and risk of dementia: the Framingham heart study. Neurology 75, 35-41.
18. de la Torre JC (2010) Alzheimer's disease is incurable but preventable. J Alzheimers Dis 20, 861-870.
19. Bishop NA, Lu T, Yankner BA (2010) Neural mechanisms of ageing and cognitive decline. Nature 464, 529-535.
20. van Praag H, Christie BR, Sejnowski TJ, Gage FH (1999) Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc Natl Acad Sci USA 96, 13427-13431.
21. Whitehouse P, George D (2008) The Myth of Alzheimer's: What You Aren't Being Told About Today's Most Dreaded Diagnosis. St. Martin's Press, New York.
22. Shoback D (2007) Update in osteoporosis and metabolic bone disorders. J Clin Endocrinol Metab 92, 747-753. (Pubitemid 46465635)
23. Snowdon DA (1997) Aging and Alzheimer's disease: lessons fromthe Nun study. Gerontologist37, 150-156. (Pubitemid 27181271)
24. Joseph J, Shukitt-Hale B, Denisova NA, Martin A, Perry G, Smith MA (2001) Copernicus revisited: amyloid beta in Alzheimer's disease. Neurobiol Aging 22, 131-146. (Pubitemid 32333008)
25. Khachaturian ZS (2000) Aging: a cause or a risk for AD? J Alzheimers Dis 2, 115-116.
26. Mattson MP (2000) Risk factors and mechanisms of Alzheimer's disease pathogenesis: obviously and obviously not. J Alzheimers Dis 2, 109-112.
27. Price JL, Phil D, Rubin EH, Morris JC (2000) Comments on revisiting Alzheimer's disease from a new prospective: can "risk factors" play a key role. J Alzheimers Dis 2, 113-114.
28. Ghanbari H (2000) Risk factors versus Alzheimer's disease or symptoms associated with Alzheimers disease. J Alzheimer Dis2, 117-118.